Manager × security

THOMPSON SIEGEL & WALMSLEY LLC BIO holdings history

Who else holds this security? →

BIO-RAD LABORATORIES-A · CUSIP 090572207 · CIK 1008322

Some filings reported values in thousands; those figures were scaled ×1000 to dollars.
This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, THOMPSON SIEGEL & WALMSLEY LLC reported 129.88K BIO (shares), valued at $38.13M, or 0.69% of its reported non-derivative portfolio. Filed 2026-08-11.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.69%
Shares
129.88K
129,881
Reported value
$38.13M
USD

Shares decreased 26.40%; reported value decreased 22.48%, and weight changed -0.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.69%129,881SEC filing ↗Filed Aug 11, 2026
Q1 20260.87%176,465SEC filing ↗Filed May 11, 2026
Q4 20250.98%191,961SEC filing ↗Filed Feb 10, 2026
Q3 20250.99%217,596SEC filing ↗Filed Nov 12, 2025
Q2 20251.25%306,132SEC filing ↗Filed Aug 6, 2025
Q1 20251.16%279,489SEC filing ↗Filed May 9, 2025
Q4 20241.33%258,153SEC filing ↗Filed Feb 10, 2025
Q3 20241.54%306,793SEC filing ↗Filed Nov 12, 2024
Q2 20241.71%390,020SEC filing ↗Filed Aug 8, 2024
Q1 20241.86%350,014SEC filing ↗Filed May 9, 2024
Q4 20231.82%348,473SEC filing ↗Filed Feb 7, 2024
Q3 20231.86%312,583SEC filing ↗Filed Nov 8, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20231.86%312,583$112.05MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 8, 2023
Q4 20231.82%348,473$112.52MShares increased 11.48%; reported value increased 0.42%, and weight changed -0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 7, 2024
Q1 20241.86%350,014$121.06MShares increased 0.44%; reported value increased 7.59%, and weight changed +0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 9, 2024
Q2 20241.71%390,020$106.52MShares increased 11.43%; reported value decreased 12.01%, and weight changed -0.15 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 8, 2024
Q3 20241.54%306,793$102.65MShares decreased 21.34%; reported value decreased 3.63%, and weight changed -0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 12, 2024
Q4 20241.33%258,153$84.81MShares decreased 15.85%; reported value decreased 17.38%, and weight changed -0.21 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 10, 2025
Q1 20251.16%279,489$68.07MShares increased 8.26%; reported value decreased 19.73%, and weight changed -0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 9, 2025
Q2 20251.25%306,132$73.88MShares increased 9.53%; reported value increased 8.53%, and weight changed +0.09 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 6, 2025
Q3 20250.99%217,596$61.01MShares decreased 28.92%; reported value decreased 17.41%, and weight changed -0.26 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 12, 2025
Q4 20250.98%191,961$58.16MShares decreased 11.78%; reported value decreased 4.67%, and weight changed -0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 10, 2026
Q1 20260.87%176,465$49.19MShares decreased 8.07%; reported value decreased 15.43%, and weight changed -0.11 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 11, 2026
Q2 20260.69%129,881$38.13MShares decreased 26.40%; reported value decreased 22.48%, and weight changed -0.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 11, 2026
THOMPSON SIEGEL & WALMSLEY LLC · BIO-RAD LABORATORIES-A

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1008322","quarter":"2026Q2","cusip":"090572207"}

get_institutional_manager_history
{"cik":"1008322","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.